Orchard Therapeutics plc (NasdaqGS:ORTX) announced that it will receive $7.5 million in equity investment on July 1, 2021. The transaction will include participation from Pharming Group N.V. (ENXTAM:PHARM) and share will be issued at premium.
1st Jan change | Capi. | |
---|---|---|
+23.88% | 562B | |
-5.99% | 358B | |
+20.90% | 322B | |
+8.30% | 297B | |
+13.68% | 219B | |
+6.43% | 199B | |
-10.27% | 196B | |
-9.67% | 149B | |
-5.73% | 146B |